Loading...

BMY BRISTOL MYERS SQUIBB CO Management Changes 8-K Filing

BRST

BMY

BRISTOL MYERS SQUIBB CO

(BMY)

2025 8-K

Show Summary

Summary

Financial Statements

Financial Statements

Management Change

Earnings Announcement

Q3 Earnings Report

Earnings Report

Appointment of Director

Amendment Approval

Earnings Release

Departure of Directors

Acquisition of Karuna Thera...

Offering of Notes

Management Changes

Mini-Tender Offer Rejected

Financial Results Announcement

Investor Presentation

Merger Agreement

Offering of Notes

Management Changes

Earnings Release

Share Repurchase Program

Earnings Release

Appointment of Christopher ...

Earnings Release

Management Changes

Acquisition and Contingent ...

Earnings Release

Departure of Dr. Rupert Vessey

Investor Presentation

External Links:

On July 25, 2025, Bristol-Myers Squibb announced that Dr. Samit Hirawat will leave his role as Chief Medical Officer by November 1, 2025, and will serve as an advisor starting August 1, 2025. He will receive severance benefits, pro-rated equity vesting, and an incentive payout for 2025.

AI Assistant

BRISTOL MYERS SQUIBB CO

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.